Skip to main content
Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
29.53
+0.75 (2.61%)
At close: Mar 9, 2026, 4:00 PM EDT
29.44
-0.09 (-0.30%)
After-hours: Mar 9, 2026, 7:33 PM EDT

Roivant Sciences Revenue

Roivant Sciences had revenue of $2.00M in the quarter ending December 31, 2025, a decrease of -77.83%. This brings the company's revenue in the last twelve months to $13.31M, down -56.36% year-over-year. In the fiscal year ending March 31, 2025, Roivant Sciences had annual revenue of $29.05M, down -11.19%.

Revenue (ttm)
$13.31M
Revenue Growth
-56.36%
P/S Ratio
1,587.88
Revenue / Employee
$17,747
Employees
750
Market Cap
21.13B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202529.05M-3.66M-11.19%
Mar 31, 202432.71M1.18M3.75%
Mar 31, 202331.53M-23.76M-42.97%
Mar 31, 202255.29M31.49M132.34%
Mar 31, 202123.80M-43.89M-64.85%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BeOne Medicines AG 5.34B
Incyte 5.14B
Genmab 3.72B
BioNTech SE 3.70B
Royalty Pharma 2.38B
Moderna 1.94B
Ionis Pharmaceuticals 943.71M
Ascendis Pharma 845.52M
Revenue Rankings

ROIV News

More News